The cost of Ocrevus (ocrelizumab) treatment in Germany typically ranges from $50,000 to $70,000. Pricing can vary depending on the clinic, the neurologist’s experience, and whether you need inpatient or outpatient care. In the United States, the average cost is $80,000 (per MSAA). Ocrevus therapy in Germany is about 25% less than in the U.S.
German clinics usually include the medication, infusion sessions, pre-infusion blood tests, and medical supervision in the total price. Follow-up consultations and monitoring are also often part of the package. In the U.S., medication, infusion fees, facility charges, and follow-ups are often billed separately. Always confirm exactly what your treatment package covers at each clinic.